AbCellera Biologics (ABCL) Change in Cash (2020 - 2026)
AbCellera Biologics' (ABCL) quarterly Change in Cash came in at -$51.4 million in Q1 2026, down 1849.4% YoY from $2.9 million in Q1 2025, and down 214.84% on a QoQ basis from $44.8 million in Q4 2025.
AbCellera Biologics (ABCL) Change in Cash (2020 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 7 years of Change in Cash data on file, last reported at -$51.4 million in Q1 2026.
- Quarterly Change in Cash fell 1849.4% year-over-year to -$51.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.8 million (down 331.85% YoY) and the FY2025 annual result came in at -$28.4 million, down 223.3% from the prior year.
- Change in Cash declined to -$51.4 million in Q1 2026, from $44.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $245.8 million in Q2 2022 to a low of -$417.4 million in Q3 2022.
- A 5-year average of -$23.4 million and a median of -$9.3 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash surged 286.42% — and 2026, when it plunged 1849.4%.
- Tracing ABCL's Change in Cash over 5 years: stood at $14.6 million in 2022, then tumbled by 368.51% to -$39.1 million in 2023, then surged by 175.92% to $29.7 million in 2024, then soared by 50.92% to $44.8 million in 2025, then tumbled by 214.84% to -$51.4 million in 2026.
- The last three Change in Cash figures came in at -$51.4 million (Q1 2026), $44.8 million (Q4 2025), and -$9.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | 43.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.23 Mn |
| Mar 31, 2026 | -51.45 Mn |
| Dec 31, 2025 | 44.80 Mn |
| Sep 30, 2025 | -9.28 Mn |
| Jun 30, 2025 | -66.83 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 29.69 Mn |
| Sep 30, 2024 | -21.67 Mn |
| Jun 30, 2024 | 24.74 Mn |
| Mar 31, 2024 | -9.75 Mn |
| Dec 31, 2023 | -39.10 Mn |
| Sep 30, 2023 | -7.33 Mn |
| Jun 30, 2023 | -13.27 Mn |
| Mar 31, 2023 | -194.34 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | -417.35 Mn |
| Jun 30, 2022 | 245.78 Mn |
| Mar 31, 2022 | 70.51 Mn |
| Dec 31, 2021 | -16.55 Mn |
| Sep 30, 2021 | -274.88 Mn |